The databook is designed to serve as a comprehensive guide to navigating this
sector. The databook focuses on market statistics denoted in the form of
revenue and y-o-y growth and CAGR across the globe and regions. A detailed
competitive and opportunity analyses related to infectious disease molecular diagnostics market will
help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of
66.71% in
2020.
Horizon Databook has segmented the Global infectious disease molecular diagnostics market based on instruments, reagents covering the revenue growth of each sub-segment from 2018 to
2028.
- Global Infectious Disease Molecular Diagnostics Product Outlook (Revenue, USD Million, 2018-2028)
- Instruments
- Reagents
- Others
- Global Infectious Disease Molecular Diagnostics Test location Outlook (Revenue, USD Million, 2018-2028)
- Hospitals
- Clinics
- Diagnostics Laboratories
- Research Institutes
- Global Infectious Disease Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2018-2028)
- PCR
- Nucleic Acid Extraction
- Others
- In Situ Hybridization
- Instruments
- Reagents
- Others
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Instruments
- Reagents
- Others
- Chips and microarrays
- Instruments
- Reagents
- Others
- Mass spectrometry
- Instruments
- Reagents
- Others
- Sequencing
- Instruments
- Reagents
- Others
- Transcription Mediated Amplification
- Instruments
- Reagents
- Others
- Others
- Instruments
- Reagents
- Others
- Global Infectious Disease Molecular Diagnostics Application Outlook (Revenue, USD Million, 2018-2028)
- Respiratory Diseases
- Tuberculosis
- Meningitis
- Gastrointestinal Tract Infections
- HPV
- Sexually Transmitted Infection
- Sepsis
- Drug Resistance Disease
- Other Infectious Diseases
Reasons to
subscribe to Global infectious disease molecular diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of
Global infectious disease molecular diagnostics market databook
-
Our clientele includes a mix of infectious disease molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed
overview of
global-level
data and insights on the Global infectious disease molecular diagnostics market , including
forecasts for subscribers. This
global
databook contains high-level insights into
Global infectious disease molecular diagnostics market from
2018 to
2028, including revenue
numbers, major trends, and company profiles.